Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04752384 · ClinicalTrials.gov registry record · Phase 2
Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients
A Phase 2 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT04752384 is a Phase 2 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 20 participants.
The verdict
NCT04752384, a Phase 2 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a single-arm prospective clinical trial to determine the safety and feasibility of using transdermal buprenorphine in alleviation of radiation induced mucositis pain in head and neck cancer patients.
Interventions
- DRUG Buprenorphine
- DRUG Tramadol
- DEVICE Oral Mucositis (OM) Pain App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-07-08 |
| Est. Completion | 2024-04-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04752384
The ClinicalTrials.gov registry entry for NCT04752384 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Buprenorphine is the first listed.
NCT04752384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04752384 about?
NCT04752384 is a clinical study titled "Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients". This is a single-arm prospective clinical trial to determine the safety and feasibility of using transdermal buprenorphine in alleviation of radiation induced mucositis pain in head and neck cancer patients.
What is the current status of trial NCT04752384?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2021-07-08. Estimated completion is 2024-04-04.
What interventions are being tested in trial NCT04752384?
The interventions under investigation include: Buprenorphine (DRUG), Tramadol (DRUG), Oral Mucositis (OM) Pain App (DEVICE).
Who is sponsoring clinical trial NCT04752384?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.